05 августа 2002 15:19 |
Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy
Background. It remains controversial whether transcervical thymectomy offers results equivalent to thymectomy by way of a median sternotomy in the treatment of myasthenia gravis. Furthermore, preoperative prognostic factors have not been clearly defined.
Methods. This study is a retrospective chart review and interview of 78 patients completing transcervical thymectomy for myasthenia gravis between 1992 and 1999.
Results. There were 24 men and 54 women. Mean age was 40 years (range, 13 to 78 years). Twelve patients were in Osserman class 1, 25 in class 2, 30 in class 3, and 11 in class 4 (mean, 2.5). There was no perioperative mortality and 6 (7.7%) morbidities. Mean length of stay was 1.5 days and mean follow-up, 54.6 months. The crude cumulative complete remission (asymptomatic off medications for 6 months) rate was 39.7% (n = 31). Only 8 patients (10.3%) failed to improve after transcervical thymectomy. Kaplan-Meier estimates of complete remission were 31% and 43% at 2 and 5 years, respectively. Eight patients with thymoma had a 5−year estimated complete remission rate of 75% in contrast to 43% in 38 patients with thymic hyperplasia and 36% in 32 patients with neither thymoma nor hyperplasia (p = 0.01). Twelve patients with ocular myasthenia had a 5−year estimated complete remission rate of 57%, whereas patients with mild-to-moderate (n = 55) or severe (n = 11) generalized symptoms had 5−year complete remission rates of 43% and 30%, respectively (p = 0.21).
Conclusions. Overall, extended transcervical thymectomy offers results that are comparable to those published for the transsternal procedure. Patients with milder disease (including isolated ocular disease) and taking no preoperative immunosuppressive agents appear to experience higher remission rates. In contrast to previous studies, we also find that small thymomas predict better responses to thymectomy.
Смотри также
05 августа 2002 | 15:08
Outcomes after minimally invasive reoperation for gastroesophageal reflux disease
Background. Reoperative antireflux surgery is complex and traditionally performed by open methods. Increasingly, surgeons are performing minimally invasive reoperations. This report summarizes
05 августа 2002 | 15:08
Surgical treatment of tracheomalacia by bronchoscopic monitored aortopexy in infants and children
Background. Aortopexy has become an established surgical procedure for the treatment of severe tracheomalacia (TM) in infancy. However, postoperative outcome may be improved by intraoperative
05 августа 2002 | 15:08
Pediatric tracheal surgery
Background. Pediatric tracheal procedures are uncommon. We reviewed our experience to clarify management and results.
Methods. Retrospective single-institution review of pediatric tracheal operations,
15 июля 2002 | 00:07
ЗАНТАК В ТЕРАПИИ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ
Соляная кислота ( HCl ) секретируется париетальными клетками, располагающимися в главных железах тела желудка. Основными функциями HCl являются: а) активация пепсиногена с превращением его в
15 июля 2002 | 00:07
ЭФФЕКТИВНОСТЬ РАНИТИДИНА (ЗАНТАКА) В ЛЕЧЕНИИ РЕФЛЮКС-ЭЗОФАГИТА И ЯЗВЕННОЙ БОЛЕЗНИ
В связи с созданием высокоэффективных медикаментозных препаратов, обладающих антикислотным действием, и уточнением этиологии и патогенеза кислотозависимых заболеваний пищеварительного тракта
